Pulmonary artery denervation

PROCEDURE3 trials

Sponsors

SoniVie Inc., Meshalkin Research Institute of Pathology of Circulation, Pulnovo Medical (Wuxi) Co., Ltd.

Conditions

Atrial FibrillationHeart FailurePulmonary Arterial HypertensionPulmonary Hypertension

Unknown Phase

TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study

SoniVie Inc.Pulmonary Arterial Hypertension

Start: 2023-01-01End: 2025-12-01Target: 205Updated: 2022-04-01

Pulmonary Artery Denervation in Patients With Atrial Fibrillation and Group 2 of Pulmonary Hypertension

Meshalkin Research Institute of Pathology of CirculationAtrial Fibrillation, Pulmonary Hypertension

Start: 2023-05-22End: 2025-02-22Target: 116Updated: 2023-05-25

Study for Evaluation of Safety and Efficacy of PADN to Treat Combined Post- and Pre- Capillary Pulmonary Hypertension Associated With Chronic Heart Failure（PADN-CpcPH-PILOT）

CompletedNCT05996562

Pulnovo Medical (Wuxi) Co., Ltd.Heart Failure, Pulmonary Hypertension

Start: 2024-06-28End: 2026-01-15Updated: 2026-01-16